CY1105814T1 - Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστης - Google Patents
Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστηςInfo
- Publication number
- CY1105814T1 CY1105814T1 CY20061101729T CY061101729T CY1105814T1 CY 1105814 T1 CY1105814 T1 CY 1105814T1 CY 20061101729 T CY20061101729 T CY 20061101729T CY 061101729 T CY061101729 T CY 061101729T CY 1105814 T1 CY1105814 T1 CY 1105814T1
- Authority
- CY
- Cyprus
- Prior art keywords
- urine
- suboperative
- darifenakin
- treatment
- urinary bladder
- Prior art date
Links
- 210000003932 urinary bladder Anatomy 0.000 title 1
- 210000002700 urine Anatomy 0.000 title 1
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
- HXGBXQDTNZMWGS-RUZDIDTESA-N darifenacin Chemical compound C=1C=CC=CC=1C([C@H]1CN(CCC=2C=C3CCOC3=CC=2)CC1)(C(=O)N)C1=CC=CC=C1 HXGBXQDTNZMWGS-RUZDIDTESA-N 0.000 abstract 1
- 229960002677 darifenacin Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
- Processing Of Meat And Fish (AREA)
- Document Processing Apparatus (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Inorganic Insulating Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
Abstract
Η εφεύρεση παρέχει τη χρήση της δαριφενακίνης, ή ενός φαρμακευτικώς αποδεκτού παραγώγου εξ αυτών, στην κατασκευή ενός φαρμάκου για την μείωση της έπειξης προς ούρηση σε ασθενείς οι οποίοι πάσχουν από υπερλειτουργία της ουροδόχου κύστεως.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0129962.7A GB0129962D0 (en) | 2001-12-14 | 2001-12-14 | Method of treatment |
PCT/IB2002/000664 WO2003051354A1 (en) | 2001-12-14 | 2002-03-05 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1105814T1 true CY1105814T1 (el) | 2011-02-02 |
Family
ID=9927643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061101729T CY1105814T1 (el) | 2001-12-14 | 2006-11-30 | Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστης |
Country Status (28)
Country | Link |
---|---|
US (3) | US20030130338A1 (el) |
EP (1) | EP1458376B1 (el) |
JP (3) | JP2005516925A (el) |
KR (1) | KR100889086B1 (el) |
CN (1) | CN100488505C (el) |
AT (1) | ATE341323T1 (el) |
AU (1) | AU2002236141B2 (el) |
BR (1) | BR0214925A (el) |
CA (1) | CA2469702C (el) |
CY (1) | CY1105814T1 (el) |
CZ (1) | CZ301283B6 (el) |
DE (1) | DE60215219T2 (el) |
DK (1) | DK1458376T3 (el) |
ES (1) | ES2276910T3 (el) |
GB (1) | GB0129962D0 (el) |
HK (1) | HK1073779A1 (el) |
HU (1) | HU229908B1 (el) |
IL (2) | IL162391A0 (el) |
MX (1) | MXPA04005760A (el) |
NO (1) | NO20042586L (el) |
NZ (1) | NZ533421A (el) |
PL (1) | PL206034B1 (el) |
PT (1) | PT1458376E (el) |
RU (1) | RU2321398C2 (el) |
SI (1) | SI1458376T1 (el) |
SK (1) | SK287510B6 (el) |
WO (1) | WO2003051354A1 (el) |
ZA (1) | ZA200404289B (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007109142A2 (en) * | 2006-03-17 | 2007-09-27 | Oregon Health & Science University | M3 muscarinic receptor antagonists for treating tumors |
CN101084891A (zh) * | 2007-06-29 | 2007-12-12 | 北京本草天源药物研究院 | 一种用于口服的达非那新或其药用盐的药物制剂 |
CZ200845A3 (cs) * | 2008-01-28 | 2009-09-02 | Zentiva, A. S. | Zpusob prípravy Darifenacinu |
PL2394648T3 (pl) * | 2009-02-04 | 2016-12-30 | Kompozycja farmaceutyczna do podawania doustnego | |
CN102048706B (zh) * | 2011-01-12 | 2012-02-22 | 山东创新药物研发有限公司 | 一种氢溴酸达非那新缓释片及制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
-
2001
- 2001-12-14 GB GBGB0129962.7A patent/GB0129962D0/en not_active Ceased
-
2002
- 2002-03-05 JP JP2003552287A patent/JP2005516925A/ja not_active Withdrawn
- 2002-03-05 ES ES02702623T patent/ES2276910T3/es not_active Expired - Lifetime
- 2002-03-05 CN CNB028249364A patent/CN100488505C/zh not_active Expired - Lifetime
- 2002-03-05 AT AT02702623T patent/ATE341323T1/de active
- 2002-03-05 DE DE60215219T patent/DE60215219T2/de not_active Expired - Lifetime
- 2002-03-05 CA CA2469702A patent/CA2469702C/en not_active Expired - Lifetime
- 2002-03-05 NZ NZ533421A patent/NZ533421A/en not_active IP Right Cessation
- 2002-03-05 SK SK250-2004A patent/SK287510B6/sk not_active IP Right Cessation
- 2002-03-05 EP EP02702623A patent/EP1458376B1/en not_active Expired - Lifetime
- 2002-03-05 HU HU0402625A patent/HU229908B1/hu not_active IP Right Cessation
- 2002-03-05 MX MXPA04005760A patent/MXPA04005760A/es active IP Right Grant
- 2002-03-05 PL PL369426A patent/PL206034B1/pl unknown
- 2002-03-05 PT PT02702623T patent/PT1458376E/pt unknown
- 2002-03-05 RU RU2004121780/15A patent/RU2321398C2/ru active
- 2002-03-05 CZ CZ20040719A patent/CZ301283B6/cs not_active IP Right Cessation
- 2002-03-05 WO PCT/IB2002/000664 patent/WO2003051354A1/en active IP Right Grant
- 2002-03-05 SI SI200230464T patent/SI1458376T1/sl unknown
- 2002-03-05 DK DK02702623T patent/DK1458376T3/da active
- 2002-03-05 BR BR0214925-7A patent/BR0214925A/pt active Search and Examination
- 2002-03-05 AU AU2002236141A patent/AU2002236141B2/en not_active Expired
- 2002-03-05 KR KR1020047009000A patent/KR100889086B1/ko active IP Right Grant
- 2002-03-05 IL IL16239102A patent/IL162391A0/xx unknown
- 2002-09-26 US US10/256,420 patent/US20030130338A1/en not_active Abandoned
-
2004
- 2004-06-01 ZA ZA2004/04289A patent/ZA200404289B/en unknown
- 2004-06-07 IL IL162391A patent/IL162391A/en active IP Right Grant
- 2004-06-18 NO NO20042586A patent/NO20042586L/no not_active Application Discontinuation
-
2005
- 2005-07-25 HK HK05106309.8A patent/HK1073779A1/xx not_active IP Right Cessation
-
2006
- 2006-11-30 CY CY20061101729T patent/CY1105814T1/el unknown
-
2007
- 2007-07-19 US US11/880,006 patent/US20070264333A1/en not_active Abandoned
-
2009
- 2009-03-04 US US12/397,433 patent/US8748476B2/en not_active Expired - Lifetime
- 2009-10-30 JP JP2009250519A patent/JP2010024244A/ja not_active Withdrawn
-
2013
- 2013-07-11 JP JP2013145736A patent/JP2013199506A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1404331T3 (da) | Sustained release-formuleringer af oxymorphon | |
CY1105082T1 (el) | Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας | |
HRP20050439B1 (en) | New use of dextran sulfate | |
CY1112395T1 (el) | Δισκιο βαλσαρτανης | |
EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
CY1108377T1 (el) | Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων | |
DK1663244T3 (da) | Pteridin-derivater til behandling af TNF-alpha-beslægtede sygdomme | |
CY1107465T1 (el) | Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων | |
CY1105814T1 (el) | Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστης | |
DK1339407T3 (da) | Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom | |
CY1112173T1 (el) | Η χρηση της cilobradine ή των φαρμακευτικα αποδεκτων αλατων αυτης για την θεραπεια ή την προληψη της καρδιακης ανεπαρκειας | |
NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
UY28017A1 (es) | Tratamiento terapéutico | |
DK1315496T3 (da) | Behandling af inflammatoriske lidelser | |
DK1244438T3 (da) | Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde | |
ITTO20000441A0 (it) | Composizione terapeutica per la cura della psoriasi. | |
NO20034357L (no) | Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi | |
CY1106129T1 (el) | Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος | |
CY1105308T1 (el) | Θepαπεια για υπep-ουρικαιμια | |
CY1118581T1 (el) | Νεα χρηση για αλφα-συμπαθομιμητικα με δομη 2-ιμιδαζολινης | |
EA200300789A1 (ru) | Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи | |
CY1117413T1 (el) | Συνθεσεις οξυκωδονης για χορηγηση μια φορα την ημερα | |
EE200300379A (et) | Alküülfenüüliminoimidasolidiini derivaadid uriinipidamatuse ravimiseks |